Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging

Journal of Ultrasound in Medicine

Volumn 22, Issue 9, 2003, Pages 911-920

  Youk, Ji Hyun ^a   Lee, Jeong Min ^b   Kim, Chong Soo ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Agent detection imaging; Contrast media; Interventional; Liver; Neoplasms; Radiography; Ultrasonograpy

Indexed keywords

CATHETERS; CELLS; COMPUTERIZED TOMOGRAPHY; ETHANOL; GASTROENTEROLOGY; MAGNETIC RESONANCE IMAGING;

HEPATIC MASSES;

ULTRASONIC IMAGING;

ALCOHOL; CONTRAST MEDIUM; IOPROMIDE; SHU 508;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CATHETER ABLATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEVICE; FEMALE; FOLLOW UP; HUMAN; HYPEREMIA; IMAGING; INTERVENTIONAL RADIOLOGY; LIVER CANCER; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VASCULARIZATION;

EID: 0042836834     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2003.22.9.911     Document Type: Article

References (35)

1. Dodd GD III, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignani: hepatic tumors: at the threshold of a major breakthrough. Radiographics 2000; 20:9-27.
2. Bartolozzi C, Lencioni R, Caramella D, Falaschi F, Cioni R, DiCoscio G. Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology 1994; 191:123-128.
3. Choi BI, Kim HC, Han JK, et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 1992; 182:709-713.
4. Lencioni R, Caramella D, Bartolozzi C. Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology 1995; 194:113-118.
5. Sumi S, Yamashita Y, Mitsuzaki K, et al. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma. AJR Am J Roentgenol 1999; 172:67-71.
6. Tanaka K, Inoue S, Numata K, et al. Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization. AJR Am J Roentgenol 1992; 158:541-546.
7. Goldberg SN, Gazelle GS, Solbiati L, et al. Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol 1998; 170:1023-1028.
8. Ding H, Kudo M, Onda H, et al. Evaluation of post-treatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001; 221:721-730.
9. Shapiro RS, Wagreich J, Parsons RB, Stancato-Pasik A, Yeh HC, Lao R. Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography. AJR Am J Roentgenol 1998; 171:1203-1206.
10. Schlief R. Developments in echo-enhancing agents. Clin Radiol 1996; 51(suppl 1):5-7.
11. Choi BI, Kim AY, Lee JY, et al. Hepatocellular carcinoma: contrast enhancement with Levovist. J Ultrasound Med 2002; 21:77-84.
12. Ding H, Kudo M, Onda H, Suetomi Y, Minami T, Maekawa K. Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Radiology 2001; 220:349-356.
13. Prando A, Wallace S, Bernardino ME, Lindell MM Jr. Computed tomographic arteriography of the liver. Radiology 1979; 130:697-701.
14. Matsui O, Kadoya M, Suzuki M, et al. Work in progress: dynamic sequential computed tomography during arterial portography in the detection of hepatic neoplasms. Radiology 1983; 146:721-727.
15. Yumoto Y, Jinno K, Tokuyama K, et al. Hepatocellular carcinoma detected by iodized oil. Radiology 1985; 154:19-24.
16. Ohishi H, Uchida H, Yoshimura H, et al. Hepatocellular carcinoma detected by iodized oil: Use of anticancer agents. Radiology 1985; 154:25-29.
17. Takayasu K, Shima Y, Muramatsu Y, et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987; 163:345-351.
18. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000; 216:411-417.
19. Blomley MJ, Sidhu PS, Cosgrove DO, et al. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience. Radiology 2001; 220:661-667.
20. Matsui O, Kadoya M, Yoshikawa J, et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993; 188:79-83.
21. Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radio-frequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996; 3:636-644.
22. Shiina S, Tagawa K, Unuma T, Terano A. Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma. AJR Am J Roentgenol 1990; 154:947-951.
23. Solbiati L, Goldberg SN, lerace T, Dellanoce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent - early experience. Radiology 1999; 211:643-649.
24. Lim HK, Choi D, Lee WJ, et al. Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001; 221:447-454.
25. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response: preliminary results. Radiology 2000; 217:558-563.
26. Cioni D, Lencioni R, Bartolozzi C. Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound. Eur Radiol 2000; 10:1570-1575.
27. Numata K, Tanaka K, Kiba T, et al. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma. AJR Am J Roentgenol 2001; 176:1199-1205.
28. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217:119-126.
29. Ikeda K, Kurnada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma: an analysis by the Cox proportional hazard model. Cancer 1991; 68:2150-2154.
30. Choi D, Lim HK, Kim SH, et al. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent. J Ultrasound Med 2002; 21:391-401.
31. Kim AY, Choi BI, Kim TK, Kim KW, Lee JY, Han JK. Comparison of contrast-enhanced fundamental imaging, second-harmonic imaging, and pulse-inversion harmonic imaging. Invest Radiol 2001; 36:582-588.
32. Burns PN, Wilson SR, Muradali D, Powers JE, Greener Y. Microbubble destruction is the origin of harmonic signals from FS069 [abstract]. Radiology 1996; 201 (suppl):158.
33. Kim TK, Choi BI, Hong HS, Choi BY, Han JK. Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using contrast agent SH U 508A: preliminary study. Ultrasound Med Biol 2000; 26:1439-1444.
34. Solbiati L, lerace T, Goldberg SN, et al. Percutaneous US-guided radiofrequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202:195-203.
35. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000; 88:2452-2463.